Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

LL-37 Biofilm Disruption Research: Activity Comparison

Before selecting LL-37 for biofilm research, understanding how it compares to alternative antimicrobial peptides and conventional treatments clarifies its specific advantages and limitations in experimental design. LL-37 Matrix penetration + membrane disruptio

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before selecting LL-37 for biofilm research, understanding how it compares to alternative antimicrobial peptides and conventional treatments clarifies its specific advantages and limitations in experimental design.
  • LL-37
  • Matrix penetration + membrane disruption + quorum sensing modulation
  • 10–50 μg/mL depending on species
  • Higher concentrations required than planktonic MIC; potential host cell toxicity above 80 μg/mL
  • Best choice for mechanistic biofilm studies; multi-target activity prevents rapid resistance
  • Colistin
  • Membrane disruption via LPS binding (Gram-negative only)
  • 20–100 μg/mL
  • No matrix-degrading activity; limited to Gram-negatives; nephrotoxicity limits clinical translation
  • Effective against Gram-negative biofilms but lacks LL-37's matrix penetration; use when studying LPS interactions specifically
  • Human Beta-Defensin-3 (hBD-3)
  • eDNA binding + membrane disruption
  • 30–80 μg/mL
  • Less effective against mature biofilms; stronger prophylactic than therapeutic
  • Complements LL-37 in combination studies; stronger anti-formation than anti-established biofilm activity
  • Tobramycin
  • Ribosomal protein synthesis inhibition (requires intracellular penetration)
  • 100–500 μg/mL (1000× planktonic MIC)
  • Cannot penetrate biofilm matrix without adjuvant; rapidly develops resistance in biofilms
  • Poor monotherapy choice for biofilm research; include only in combination with matrix-disrupting agents like LL-37
  • Ciprofloxacin
  • DNA gyrase inhibition (requires intracellular penetration)
  • 50–200 μg/mL (50–100× planktonic MIC)
  • Minimal matrix penetration; persister cells survive in biofilms
  • Demonstrates the limitation LL-37 overcomes; use as negative control in penetration studies
  • EDTA
  • Chelates divalent cations that stabilize biofilm matrix
  • 1–5 mM
  • No direct bactericidal activity; disrupts matrix but doesn't kill bacteria
  • Pair with LL-37 for mechanistic studies separating matrix disruption from bactericidal effects